ZUMA-8: A Phase 1 Study of KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy, in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

被引:8
|
作者
Davids, Matthew S. [1 ]
Kenderian, Saad S. [2 ]
Flinn, Ian W. [3 ]
Hill, Brian T. [4 ]
Maris, Michael [5 ]
Ghia, Paolo [6 ]
Byrne, Michael [7 ]
Bartlett, Nancy L. [8 ]
Pagel, John M. [9 ]
Zheng, Yan [10 ]
Kanska, Justyna [10 ]
Zhang, Wangshu [10 ]
Masouleh, Behzad Kharabi [10 ]
Granados, Enrique [10 ]
Ibarz, Javier Pinilla [11 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Mayo Clin, Div Hematol, Dept Med, Rochester, MN USA
[3] Sarah Cannon Res Inst, Tennessee Oncol, Nashville, TN USA
[4] Cleveland Clin Fdn, Taussig Canc Inst, Dept Hematol & Med Oncol, 9500 Euclid Ave, Cleveland, OH 44195 USA
[5] Sara Cannon Res Inst, Denver, CO USA
[6] Univ Vita Salute San Raffaele, Milan, Italy
[7] Vanderbilt Univ, Dept Med, Div Hematol & Oncol, Nashville, TN USA
[8] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA
[9] Univ Washington, Sch Med, Swedish Canc Inst, Divison Oncol, Seattle, WA USA
[10] Kite, Santa Monica, CA USA
[11] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
关键词
D O I
10.1182/blood-2022-167868
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:7454 / 7456
页数:3
相关论文
共 50 条
  • [2] Updated Phase 1 Results of Zuma-3: Kte-X19, an Anti-CD19 Chimeric Antigen Receptor T Cell Therapy, in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
    GWierda, William
    Bishop, Michael R.
    Oluwole, Olalekan
    Logan, Aaron C.
    Baer, Maria R.
    Donnellan, William B.
    O'Dwyer, Kristen M.
    Castro, Januario E.
    Schiller, Gary J.
    Holmes, Houston
    Abedi, Mehrdad
    Ghobadi, Armin
    Arellano, Martha L.
    Malone, Adriana K.
    Pagel, John M.
    Mardiros, Armen
    Shen, Tong
    Vezan, Remus
    Jain, Rajul K.
    Shah, Bijal D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [3] KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results
    Shah, Bijal D.
    Bishop, Michael R.
    Oluwole, Olalekan O.
    Logan, Aaron C.
    Baer, Maria R.
    Donnellan, William B.
    O'Dwyer, Kristen M.
    Holmes, Houston
    Arellano, Martha L.
    Ghobadi, Armin
    Pagel, John M.
    Lin, Yi
    Cassaday, Ryan D.
    Park, Jae H.
    Abedi, Mehrdad
    Castro, Januario E.
    DeAngelo, Daniel J.
    Malone, Adriana K.
    Mawad, Raya
    Schiller, Gary J.
    Rossi, John M.
    Bot, Adrian
    Shen, Tong
    Goyal, Lovely
    Jain, Rajul K.
    Vezan, Remus
    Wierda, William G.
    BLOOD, 2021, 138 (01) : 11 - 22
  • [4] KTE-X19, an anti-CD19 chimeric antigen receptor T-cell therapy, in patients with relapsed/refractory mantle cell lymphoma: results from phase 2 of ZUMA-2
    Wang, M.
    Munoz, J.
    Goy, A.
    Locke, F.
    Jacobson, C.
    Hill, B.
    Timmerman, J.
    Holmes, H.
    Jaglowski, S.
    Flinn, I.
    McSweeney, P.
    Miklos, D.
    Pagel, J.
    Kersten, M. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 28 - 29
  • [5] KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL): Results of the Phase 2 ZUMA-2 Study
    Wang, Michael
    Munoz, Javier
    Goy, Andre
    Locke, Frederick L.
    Jacobson, Caron A.
    Hill, Brian T.
    Timmerman, John M.
    Holmes, Houston
    Jaglowski, Samantha
    Flinn, Ian W.
    McSweeney, Peter A.
    Miklos, David B.
    Pagel, John M.
    Kersten, Marie Jose
    Peng, Weimin
    Zheng, Lianqing
    Rossi, John M.
    Jain, Rajul K.
    Rao, Arati V.
    Reagan, Patrick M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S1 - S1
  • [6] KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) With Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Results of the Phase 2 ZUMA-2 Study
    Wang, Michael L.
    Munoz, Javier
    Goy, Andre
    Locke, Frederick L.
    Jacobson, Caron A.
    Hill, Brian T.
    Timmerman, John M.
    Holmes, Houston
    Jaglowski, Samantha
    Flinn, Ian W.
    McSweeney, Peter A.
    Miklos, David B.
    Pagel, John M.
    Kersten, Marie Jose
    Peng, Weimin
    Zheng, Lianqing
    Rossi, John M.
    Jain, Rajul K.
    Rao, Arati V.
    Reagan, Patrick M.
    BLOOD, 2019, 134
  • [7] KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients with Relapsed/refractory (R/R) Mantle Cell Lymphoma (MCL): Results from Phase 2 of ZUMA-2
    Wang, Michael
    Munoz, Javier
    Goy, Andre
    Locke, Frederick
    Jacobson, Caron
    Hill, Brian
    Timmerman, John
    Holmes, Houston
    Jaglowski, Samantha
    Flinn, Ian
    McSweeney, Peter
    Miklos, David
    Pagel, John
    Kersten, Marie Jose
    Peng, Weimin
    Zheng, Lianqing
    Rossi, John
    Jain, Rajul
    Rao, Arati
    Reagan, Patrick
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 41 - 43
  • [8] KTE-X19, an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, in Patients (Pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL): Results from Phase 2 of ZUMA-2
    Wang, Michael
    Munoz, Javier
    Goy, Andre
    Locke, Frederick L.
    Jacobson, Caron A.
    Hill, Brian T.
    Timmerman, John M.
    Holmes, Houston
    Jaglowski, Samantha
    Flinn, Ian W.
    McSweeney, Peter A.
    Miklos, David B.
    Pagel, John M.
    Kersten, Marie Jose
    Peng, Weimin
    Zheng, Lianqing
    Rossi, John M.
    Jain, Rajul K.
    Rao, Arati V.
    Reagan, Patrick M.
    MOLECULAR THERAPY, 2020, 28 (04) : 573 - 573
  • [9] End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL).
    Shah, Bijal D.
    Bishop, Michael Russell
    Oluwole, Olalekan O.
    Logan, Aaron
    Baer, Maria R.
    Donnellan, William Bruce
    Carr-O'Dwyer, Kristen Marie
    Holmes, Houston
    Arellano, Martha Lucia
    Ghobadi, Armin
    Pagel, John M.
    Lin, Yi
    Cassaday, Ryan Daniel
    Park, Jae Hong
    Mardiros, Armen
    Shen, Tong
    Goyal, Lovely
    Vezan, Remus
    Jain, Rajul K.
    Wierda, William G.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Biomarkers of Response to Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Chronic Lymphocytic Leukemia
    Fraietta, Joseph A.
    Lacey, Simon F.
    Wilcox, Nicholas S.
    Bedoya, Felipe
    Chen, Fang
    Orlando, Elena
    Brogdon, Jennifer L.
    Hwang, Wei-Ting
    Frey, Noelle
    Young, Regina M.
    Pequignot, Edward
    Ambrose, David E.
    Levine, Bruce L.
    Bitter, Hans
    Porter, David L.
    Xu, Jun
    June, Carl H.
    Melenhorst, Jan Joseph
    BLOOD, 2016, 128 (22)